Ischaemia Clinical Trials

10 recruitingLast updated: May 13, 2026

There are 10 actively recruiting ischaemia clinical trials across 4 countries. Studies span Not Applicable, Phase 4, Phase 1, Phase 3. Top locations include Beijing, China, Dublin, Ireland, Hangzhou, Zhejiang, China. Updated daily from ClinicalTrials.gov.


Ischaemia Trials at a Glance

10 actively recruiting trials for ischaemia are listed on ClinicalTrialsFinder across 3 cities in 4 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Beijing, Dublin, and Hangzhou. Lead sponsors running ischaemia studies include Professor Joseph Selvanayagam, Flinders University Faculty of Health Sciences, and Dr Mark Simmonds.

Browse ischaemia trials by phase

Treatments under study

About Ischaemia Clinical Trials

Looking for clinical trials for Ischaemia? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Ischaemia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Ischaemia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting
Not Applicable

Coronary CT-Derived FFR-Guided Strategy Versus Medical Therapy

Myocardial ischaemiaCoronary Artery Disease
Second Affiliated Hospital, School of Medicine, Zhejiang University1,066 enrolled1 locationNCT05824520
Recruiting

Implementation of a Standardized Algorithm for Coronary Calcification With Plaque Modification

Myocardial ischaemiaCoronary CalcificationSeverely Calcified Coronary Stenoses
Royal College of Surgeons, Ireland500 enrolled1 locationNCT06678594
Recruiting
Phase 4

Can eye drops safely replace reading glasses in older adults?

Retinal ischaemiaPresbyopia
The University of Auckland24 enrolled1 locationACTRN12624000383561
Recruiting
Not Applicable

Monitoring of Heart to Guide Myocardial Injury Patients to Wean From Ventilation

Myocardial Ischaemia During Surgery
Peking University People's Hospital200 enrolled1 locationNCT06240104
Recruiting

Multivessel compared to Single Vessel Functional Angiography to Diagnose Patients with No Obstructive Coronary Artery Disease: The MAD-NOCA trial

Coronary ischaemiaAngina
Concord Repatriation General Hospital72 enrolled2 locationsACTRN12622001521718
Recruiting
Phase 1

Mesenchymal Stem Cells (MSC) for the amelioration of ischaemia-reperfusion injury (IRI) after deceased donor renal transplantation, a phase 1 pilot study

Ischaemia reperfusion injuryKidney Transplantation
Royal Perth Hospital10 enrolled1 locationACTRN12615000678594
Recruiting

Cardiovascular Magnetic Resonance Imaging study assessing myocardial ischemia in patients with end-stage renal disease and renal transplant - End Stage Renal Disease cohort

myocardial ischaemia in end stage renal disease patients
Professor Joseph Selvanayagam80 enrolled1 locationACTRN12611000785909
Recruiting

Cardiovascular Magnetic Resonance Imaging study assessing myocardial ischemia in patients with end-stage renal disease and renal transplant - post renal transplant cohort

Myocardial Ischaemia in patients with renal disease
Professor Joseph Selvanayagam80 enrolled1 locationACTRN12611000783921
Recruiting
Phase 3

Arginine and wound healing in patients with critical limb ischaemia recovering from a bypass graft

Lower-limb ischaemia
Flinders University Faculty of Health Sciences20 enrolled1 locationACTRN12608000419369
Recruiting
Phase 4

Oxygen therapy and myocardial ischaemia during exercise testing

Myocardial ischaemia
Dr Mark Simmonds20 enrolled1 locationACTRN12607000202460